Florida 2024 Regular Session

Florida House Bill H7085

Introduced
2/22/24  
Introduced
2/22/24  
Engrossed
2/28/24  
Refer
2/22/24  
Engrossed
2/28/24  
Engrossed
3/6/24  
Refer
2/28/24  
Engrossed
3/6/24  
Passed
5/31/24  
Enrolled
3/6/24  
Chaptered
6/3/24  
Passed
5/31/24  

Caption

Sickle Cell Disease

Impact

The bill modifies existing laws related to sickle cell disease screening by requiring that newborn and infant screening results be communicated directly to the parents or guardians, instead of relying solely on primary care physicians. Moreover, it allows individuals beyond newborns, who are identified as carrying the disease or trait, to opt into a sickle cell registry. This legislative framework not only aims to streamline healthcare processes but also seeks to foster a more coordinated response to sickle cell disease management across the state.

Summary

House Bill 7085, concerning sickle cell disease, establishes the Sickle Cell Disease Research and Treatment Grant Program within the Florida Department of Health. The program is designed to improve the quality and accessibility of healthcare services for individuals with sickle cell disease, as well as to enhance research efforts in this area. It authorizes the department to award grants to community-based treatment and research centers focusing on various projects aimed at raising awareness, providing education, and improving health outcomes for those affected by the disease.

Sentiment

The sentiment surrounding HB 7085 appears to be positive, reflecting a collective acknowledgment of the need for enhanced healthcare provisions for sickle cell disease. Supporters emphasize the importance of accessible treatment and comprehensive research funding, particularly for communities disproportionately affected by this genetic disorder. However, concerns may arise regarding the adequacy of funding and resource allocation, highlighting the perpetual challenges of ensuring efficiency and equal access in public health initiatives.

Contention

A notable point of contention revolves around the effectiveness of the grant program in achieving its objectives. While proponents argue that the dedicated funding and focus on best practices will significantly enhance care quality, skeptics question whether the allocation of resources will adequately meet the diverse needs of affected populations. Furthermore, the broad definitions and terms used in the bill could result in varied interpretations, potentially leading to disparities in program implementation at the local level.

Companion Bills

FL S1582

Similar To Department of Health

FL S7070

Similar To Sickle Cell Disease Research and Treatment Education

Similar Bills

LA HB732

Requires all private and public facilities to report psychiatric inpatient and crisis stabilization beds at least once daily (OR SEE FISC NOTE GF EX)

CA SB452

Ken Maddy California Cancer Registry.

DE HB285

An Act To Amend Title 16 Of The Delaware Code Relating To Medical Marijuana.

CA SB1442

Point-of-care tests for fentanyl.

MN SF2418

Provider Orders for Life-Sustaining Treatment Program Act establishment, certain acts immunity establishment, and appropriation

MN HF1810

Commissioner of health required to establish a provider orders for life-sustaining treatment program, rulemaking authorized, data classified, immunity established for certain acts, and money appropriated.

PA HB493

In general provisions, repeals and effective date, providing for acute care mental health bed registry and referrals.

MN HF474

Commissioner of health required to study issues related to development of statewide registry for provider orders for life-sustaining treatment, and report required.